Clinical Trial Update: Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction [NA]

View source ↗

Summary

A recruiting trial evaluating discontinuation of beta-blockers in patients with heart failure and preserved ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: UConn Health | Conditions: Heart Failure With Preserved Ejection Fraction | NA | Status: RECRUITING